Sennosides Tablet
FDA Label NDC 62993-0001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Morepen Laboratories Limited for the product Sennosides (NDC 62993-0001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient section label, purpose section label, indications & usage section label, dosage & administration section label, inactive ingredients section label, questions section label, warnings section, keep out of reach of children section label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.